Health & Fitness

According to FutureWise analysis the market for multiple myeloma in 2026 is US$ 27.56 billion, and is expected to reach US$ 46.18 billion by 2036 at a CAGR of 5.30%. Market growth is driven by the rising global incidence of hematologic cancers and the adoption of advanced therapies like proteasome inhibitors, immunomodulatory drugs, monoclonal antibodies, and CAR-T cell therapies. Continuous innovation in targeted treatments and combination regimens is improving survival rates and patient outcomes, while expanding access to novel biologics and personalized medicine is expected to further enhance market expansion. Multiple myeloma is a type of blood cancer characterized by the abnormal growth of plasma cells, which are specialized white blood cells that play a crucial role in generating antibodies to combat infections. These plasma cells predominantly reside in the bone marrow—the soft tissue found within bones where blood cells are produced. In the case of multiple myeloma, ... Continue reading →

Hybrid contact lenses are an innovative vision-correction solution that combines the best features of traditional soft contact lenses and “hard” gas permeable (GP) lenses. Designed to deliver exceptional visual clarity with improved comfort, hybrid contact lenses have been used for decades by millions of Americans and continue to grow in popularity worldwide. If you are searching for sharper vision without sacrificing comfort, hybrid contact lenses may be the ideal option. What Are Hybrid Contact Lenses? Hybrid contact lenses consist of a rigid gas permeable center surrounded by a soft outer skirt. This unique design allows wearers to experience the crisp, high-definition vision typically associated with GP lenses, while enjoying the comfort and stability of soft lenses. Unlike standard hard lenses, hybrid contact lenses are more comfortable to wear and easier to adapt to, making them suitable for both new and experienced contact lens users. Originally introduced in the ... Continue reading →

According to FutureWise analysis the market for multiple reaction monitoring assay in 2026 is US$ 0.65 billion, and is expected to reach US$ 1.10 billion by 2036 at a CAGR of 5.40%. Market growth is fueled by increased use of mass spectrometry-based proteomics in clinical diagnostics and pharmaceutical research. The high sensitivity and specificity of MRM assays allow for precise protein and peptide quantification, while their applications in personalized medicine and drug development drive further market expansion. The multiple reaction monitoring (MRM) method is a highly selective and sensitive approach for quantifying proteins and peptides in complex biological samples. Utilizing mass spectrometry, this technique targets and detects specific proteins while also identifying peptides and other protein fragments of interest. The growth of the MRM assay market is anticipated to be driven by increased research and development in the biological sciences during the analysis period, as ... Continue reading →

According to FutureWise analysis, the Multi Channel Remote Ecg Monitor market in 2026 is US$0.23 billion, and is expected to reach US$0.38 billion by 2036 at a CAGR of 5.15%.  The Multi-Channel Remote ECG Monitor market is experiencing significant growth, driven by the rising prevalence of cardiovascular diseases worldwide and an increasing elderly population that requires continuous cardiac monitoring. There is a noticeable shift toward home-based healthcare and remote patient monitoring solutions, which is accelerating market adoption, particularly in developed regions. Technological advancements in wireless connectivity, miniaturization, and cloud-based data analytics are enhancing device capabilities and improving user experience. Currently, North America holds the largest market share due to its advanced healthcare infrastructure and high awareness of cardiac health management. However, the Asia-Pacific region is expected to experience the fastest growth during the forecast ... Continue reading →

According to FutureWise analysis, the market for multichannel infusion pumps is expected to register a CAGR of 6.72% from 2026 to 2036.  The multichannel infusion pumps market is experiencing significant growth, primarily due to an increase in the number of surgical procedures worldwide and a growing demand for precise drug delivery systems in critical care settings. The rising prevalence of chronic diseases, such as diabetes, cancer, and neurological disorders, necessitates accurate and continuous medication administration, which further drives market expansion. Hospitals and ambulatory surgical centers are increasingly adopting smart infusion pumps that come with integrated safety features designed to reduce medication errors and improve patient outcomes. Technological innovations, such as wireless connectivity, dose error reduction systems, and electronic medical record integration, are enhancing the functionality of these pumps and improving clinical efficiency. Moreover, the ... Continue reading →

According to FutureWise analysis, the multimodal chromatography columns market is expected to register a CAGR of 8.22% from 2026-2036.  The multimodal chromatography columns market is experiencing significant growth, primarily due to the expanding biopharmaceutical industry and the increasing demand for monoclonal antibodies, vaccines, and other biologics that require advanced purification techniques. Multimodal chromatography offers superior selectivity and resolution compared to traditional single-mode methods, making it essential for separating and purifying complex biomolecules. Rising investments in research and development, particularly in protein therapeutics and gene therapy, are accelerating the adoption of these advanced chromatography solutions. Pharmaceutical and biotechnology companies are increasingly utilizing multimodal columns to enhance process efficiency, reduce production costs, and comply with stringent regulatory requirements for product purity. ... Continue reading →

According to FutureWise analysis, the Multimodal Imaging market in 2026 is US$4.86 billion, and is expected to reach US$7.79 billion by 2036 at a CAGR of 4.83%.  The multimodal imaging market is experiencing significant growth driven by the rising demand for accurate disease diagnosis and the increasing prevalence of cancer, cardiovascular diseases, and neurological disorders. These conditions necessitate comprehensive imaging solutions. Multimodal imaging integrates various techniques, such as PET-CT, PET-MRI, and SPECT-CT, to provide improved diagnostic accuracy along with detailed anatomical and functional information in a single examination. This technology is particularly popular in oncology for tumor detection, treatment planning, and monitoring therapeutic responses. It is also used in neurology for assessing brain disorders. Innovations in imaging software, the integration of artificial intelligence, and advancements in image resolution are propelling progress and ... Continue reading →

According to FutureWise analysis, the Multiparameter Patient Monitoring Systems market in 2026 is US$13.24 billion, and is expected to reach US$22.95 billion by 2036 at a CAGR of 5.65%. The multiparameter patient monitoring systems market is experiencing significant growth due to several key factors. These factors include the increasing prevalence of chronic diseases, a growing elderly population, and the expansion of intensive care units and emergency departments worldwide. These systems enable continuous real-time monitoring of vital parameters, including heart rate, blood pressure, oxygen saturation, respiratory rate, and temperature, which are crucial for ensuring patient safety in hospital settings. Additionally, the shift toward home healthcare and remote patient monitoring, accelerated by the rise of telemedicine, is expanding the use of portable and wireless multiparameter monitoring devices beyond traditional clinical environments. Technological advancements such as ... Continue reading →

According to FutureWise analysis, the multiple sclerosis therapeutics market in 2026 is US$32.48 billion, and is expected to reach US$54.21 billion by 2036 at a CAGR of 5.26%.  The multiple sclerosis therapeutics market is experiencing significant growth, mainly due to the increasing global prevalence of multiple sclerosis, which affects an estimated 2.8 million people worldwide. The rise in diagnosis rates, driven by improved awareness and advanced diagnostic technologies, is also contributing to this growth.Innovative disease-modifying therapies, such as oral medications, monoclonal antibodies, and cell-based therapies, are transforming treatment methods and providing patients with more effective and convenient options. Additionally, the shift towards personalized medicine and the introduction of high-efficacy therapies for progressive forms of MS are expanding treatment possibilities for previously underserved patient populations.Major pharmaceutical companies are heavily ... Continue reading →

According to FutureWise analysis, the multiplex assay market in 2026 is US$4.03 billion, and is expected to reach US$8.39 billion by 2036 at a CAGR of 7.61%. A multiplex assay is a laboratory test that enables the simultaneous measurement of multiple analytes from a single sample. This technology allows researchers and healthcare providers to obtain more comprehensive information about a patient's health status. Multiplex assays are widely utilized in the life sciences industry, with applications in research, drug discovery, and clinical diagnostics. They can assess a broad range of analytes, including proteins, nucleic acids, and small molecules, and can be tailored to target specific biomarkers or disease markers. Multiplex assays are commonly based on several technologies, such as bead-based assays, microarray technologies, and next-generation sequencing (NGS) platforms. In a bead-based assay, different analytes are attached to beads of various colors, which allows them to be ... Continue reading →